Bach Ardalan
Impact in
- Oncology top 2%
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
-
- Biochemical and Molecular Research
- Cancer therapeutics and mechanisms
Papers in
- Oncology 40
- Colorectal Cancer Treatments and Studies 29
- Pancreatic and Hepatic Oncology Research 7
- Drug Transport and Resistance Mechanisms 4
-
- Biochemical and Molecular Research 26
- Cancer therapeutics and mechanisms 9
- Co-authors
- Pochi R. Subbarayan (14 shared papers)Howard Silberman (2 shared papers)Robert I. Glazer (3 shared papers)Alan S. Livingstone (16 shared papers)Hiremagalur N. Jayaram (11 shared papers)Thomas R. Fleming (3 shared papers)Franco M. Muggia (1 shared paper)James H. Doroshow (1 shared paper)
- Journals
- Cancer (6 papers)Journal of Clinical Oncology (5 papers)Biochemical Pharmacology (4 papers)Investigational New Drugs (3 papers)Cancer Chemotherapy and Pharmacology (3 papers)
- Partner nations
- United StatesUnited KingdomChile
In The Last Decade
Bach Ardalan
90 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 81
- Oncology 906
- Molecular Biology 484
- Hepatology 64
- Pharmacology 64
- Cancer Research 86
Countries citing papers authored by Bach Ardalan
This map shows the geographic impact of Bach Ardalan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bach Ardalan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bach Ardalan more than expected).
Fields of papers citing papers by Bach Ardalan
This network shows the impact of papers produced by Bach Ardalan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bach Ardalan. The network helps show where Bach Ardalan may publish in the future.
Co-authors
The 25 scholars most cited alongside Bach Ardalan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 93 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 293 | |
| 2 | 1991 | 167 | |
| 3 | 1988 | 117 | |
| 4 | Mechanisms of sensitivity and resistance of murine tumors to 5-fluorouracil. | 1980 | 65 |
| 5 | 1981 | 64 | |
| 6 | Reduction of chronic daunorubicin cardiotoxicity by ICRF-187 in rabbits. | 1981 | 56 |
| 7 | Increased thymidylate synthase gene expression in liver metastases from colorectal carcinoma: implications for chemotherapeutic options and survival. | 1999 | 54 |
| 8 | 2014 | 50 | |
| 9 | Reduction of daunorubicin lethality and myocardial cellular alterations by pretreatment with ICRF-187 in Syrian golden hamsters. | 1979 | 48 |
| 10 | 1978 | 46 | |
| 11 | 2006 | 44 | |
| 12 | 2010 | 41 | |
| 13 | 2006 | 39 | |
| 14 | 2010 | 39 | |
| 15 | 1977 | 38 | |
| 16 | Reevaluation of the maximum tolerated dose of continuous venous infusion of 5-fluorouracil with pharmacokinetics. | 1988 | 38 |
| 17 | 1981 | 37 | |
| 18 | 1998 | 33 | |
| 19 | Arsenic trioxide suppresses thymidylate synthase in 5-FU-resistant colorectal cancer cell line HT29 In Vitro re-sensitizing cells to 5-FU. | 2010 | 29 |
| 20 | Mechanism of resistance of variants of the Lewis lung carcinoma to N-(phosphonacetyl)-L-aspartic acid. | 1981 | 27 |
About Bach Ardalan
Bach Ardalan is a scholar working on Oncology, Molecular Biology, Hepatology, Pharmacology and Pulmonary and Respiratory Medicine, having authored 93 papers that have together received 2k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (29 papers), Biochemical and Molecular Research (26 papers), Cancer therapeutics and mechanisms (9 papers), Esophageal Cancer Research and Treatment (8 papers), Pancreatic and Hepatic Oncology Research (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Metastasis and carcinoma case studies (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). The work is most often cited by research in Oncology (906 citations), Molecular Biology (484 citations), Hepatology (64 citations), Pharmacology (64 citations) and Cancer Research (86 citations). Bach Ardalan has collaborated with scholars based in United States, United Kingdom and Chile. Frequent co-authors include Pochi R. Subbarayan, Howard Silberman, Robert I. Glazer, Alan S. Livingstone, Hiremagalur N. Jayaram, Thomas R. Fleming, Franco M. Muggia, James H. Doroshow, Catherine M. Tangen and Asha Mangalik. Their work appears in journals such as Cancer, Journal of Clinical Oncology, Biochemical Pharmacology, Investigational New Drugs and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.